New brand identity reflects the organization’s continued growth, strengthened capabilities, and commitment to advancing clinical research.
October 14, 2026 – Elite Clinical Network is proud to announce its official rebrand to ECN Clinical, marking an important milestone in the organization’s continued growth and evolution. The transition introduces a new name, refreshed visual identity, and redesigned corporate website at www.ecnclinical.com.
The rebrand reflects ECN Clinical’s evolution from a founder-led network into an established, multi-specialty clinical research organization. With an expanding network of research sites, experienced investigators, and dedicated clinical teams, ECN Clinical continues to strengthen its ability to support sponsors, contract research organizations (CROs), and patients across a broad range of therapeutic areas.
While the organization’s name and appearance have evolved, its commitment to delivering high-quality clinical research, fostering meaningful partnerships, and advancing patient access to clinical trials remains unchanged.
A Refreshed Identity Built on Excellence, Collaboration, and Nimbleness
ECN Clinical’s new brand identity reflects the strength of its connected network and the principles that guide its approach to clinical research.
The refreshed identity is centered on three core values:
· Excellence: Delivering high-quality clinical research through experienced investigators, dedicated teams, and a commitment to operational performance.
· Collaboration: Connecting sponsors, investigators, research professionals, and patients through a coordinated and collaborative network.
· Nimbleness: Providing the flexibility and responsiveness needed to meet the evolving demands of clinical development.
These principles reinforce ECN Clinical’s focus on building strong partnerships and delivering a flexible, efficient, and patient-centered research experience.
Introducing the New ECN Clinical Website
Alongside the rebrand, ECN Clinical has launched a redesigned corporate website at www.ecnclinical.com, providing an enhanced digital experience for sponsors, CROs, investigators, and patients.
The new website highlights the organization’s clinical research capabilities, therapeutic expertise, experienced investigators, and growing network of research sites.
With modernized navigation, updated content, and an improved user experience, the platform provides visitors with greater visibility into ECN Clinical’s capabilities and makes it easier to connect with the organization.
As part of its broader digital transformation, ECN Clinical will also introduce refreshed websites across its individual research sites, creating a more consistent and connected experience throughout the network.
One Connected Network. ONE ECN.
The transition to ECN Clinical represents more than a new name or visual identity. It reflects the organization’s continued investment in strengthening collaboration, enhancing operational capabilities, and creating a more connected clinical research network.
Through its combination of embedded and standalone research sites, ECN Clinical offers a flexible approach to clinical trial execution, connecting sponsors with experienced investigators and research teams positioned to support the specific needs of each study.
As ECN Clinical enters this next chapter, the organization remains focused on the people, partnerships, and expertise that have contributed to its success.
A new name. A refreshed identity.
About ECN Clinical
ECN Clinical, formerly Elite Clinical Network, is a multi-specialty clinical research site network supporting clinical trials across a broad range of therapeutic areas. Through its combination of embedded and standalone research sites, ECN Clinical connects sponsors and CROs with experienced principal investigators, dedicated research teams, and operational resources designed to support efficient, high-quality clinical trial execution.
Guided by the principles of excellence, collaboration, and nimbleness, ECN Clinical is committed to advancing clinical research and expanding access to innovative treatment opportunities for patients.
